Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 6, 2009, Pages 707-708

  Rubio, C ^a   Martin, M A ^a   Sánchez, D M Arranz ^a   Vidaurrazaga, C ^a   Casado, M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; INFLIXIMAB; PREDNISONE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG RESPONSE; FEMALE; HALLOPEAU ACRODERMATITIS CONTINUA; HUMAN; LETTER; PRIORITY JOURNAL; PUSTULAR PSORIASIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACRODERMATITIS; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 67649690878     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02998.x     Document Type: Letter

References (5)

1. Mang R, Ruzicka T, Stege H. Successful treatment of acrodermatitis continua of Hallopeau by the tumor necrosis factor-α inhibitor infliximab (Remicade). Br J Dermatol 2004 150 : 367 399.
2. Ahmad K, Rogers S. Three years'experience with infliximab in recalcitrant psoriasis. Clin Exp Dermatol 2006 31 : 630 633. (Pubitemid 44086786)
3. Weisshaar E, Diepgen TL. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau. J Dtsch Dermatol Ges 2007 5 : 489 492. (Pubitemid 46917320)
4. Tobin AM, Kirby B. Successful treatment of recalcitrat acrodermatitis continua of Hallopeau with adalimumab and acitretin. Br J Dermatol 2005 153 : 440 466.
5. Adisen E, Oztas M, Gurer MA. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau. Int J Dermatol 2007 46 : 1205 1207. (Pubitemid 350055896)